Skip to main content
AAN.com

Abstract

Little is known about progression, short of dementia, in vascular cognitive impairment. In the Canadian Study of Health and Aging, 149 participants (79.3 ± 6.7 years; 61% women) were found to have vascular cognitive impairment, no dementia (CIND). After 5 years, 77 participants (52%) had died and 58 (46%) had developed dementia. Women were at greater risk of dementia (OR 2.1, 1.0 to 4.5). Of 32 participants alive without dementia, cognition had deteriorated in seven and improved in four. Half of those with vascular CIND developed dementia within 5 years, suggesting a target for preventive interventions.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Hachinski V. Vascular dementia: a radical redefinition. Dementia . 1994; 5: 130–132.
2.
Graham JE, Rockwood K, Beattie BL, et al. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet . 1997; 349: 1793–1796.
3.
Ebly EM, Hogan DB, Parhad IM. Cognitive impairment in the non-demented elderly: results from the Canadian Study of Health and Aging. Arch Neurol . 1995; 52: 612–619.
4.
Ritchie K, Touchon J. Mild cognitive impairment: conceptual basis and current nosological status. Lancet . 2000; 355: 225–228.
5.
Rockwood K, Wentzel C, Hachinski V, Hogan DB, MacKnight C, McDowell I. Prevalence and outcomes of vascular cognitive impairment. Neurology . 2000; 54: 447–451.
6.
Canadian Study of Health and Aging Working Group. Canadian Study of Health and Aging: study methods and prevalence of dementia. Can Med Assoc J . 1994; 150: 899–913.
7.
Canadian Study of Health and Aging Working Group. The incidence of dementia. Neurology . 2000; 55: 66–73.
8.
Teng EL, Chui HC. The Modified Mini-Mental State (3MS) Examination. J Clin Psychiatry . 1987; 48: 314–318.
9.
Graham JE, Rockwood K, Beattie BL, McDowell I, Eastwood R, Gauthier S. Standardization of the diagnosis of dementia in the Canadian Study of Health and Aging. Neuroepidemiology . 1996; 15: 246–256.
10.
Roth M, Tym E, Mountjoy CQ, et al. CAMDEX: a standardised instrument for the diagnosis of mental disorders in the elderly. Br J Psychiatry . 1986; 149: 698–709.

Information & Authors

Information

Published In

Neurology®
Volume 57Number 4August 28, 2001
Pages: 714-716
PubMed: 11524488

Publication History

Received: November 28, 2000
Accepted: April 12, 2001
Published online: August 28, 2001
Published in print: August 28, 2001

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

C. Wentzel, PhD
From Dalhousie University (Drs. Wentzel, Rockwood, and MacKnight), Halifax, Nova Scotia; University of Western Ontario (Dr. Hachinski), London; University of Calgary (Dr. Hogan), Alberta; University of British Columbia (Dr. Feldman), Vancouver; McGill University (Drs. Wolfson and Gauthier), Montréal, Quebéc; Université Laval (Dr. Verreault), Quebéc City, Quebéc; University of Ottawa (Dr. McDowell), Ontario, Canada; and Duke University Medical Center (Dr. Østbye), Durham, NC.
K. Rockwood, MD
From Dalhousie University (Drs. Wentzel, Rockwood, and MacKnight), Halifax, Nova Scotia; University of Western Ontario (Dr. Hachinski), London; University of Calgary (Dr. Hogan), Alberta; University of British Columbia (Dr. Feldman), Vancouver; McGill University (Drs. Wolfson and Gauthier), Montréal, Quebéc; Université Laval (Dr. Verreault), Quebéc City, Quebéc; University of Ottawa (Dr. McDowell), Ontario, Canada; and Duke University Medical Center (Dr. Østbye), Durham, NC.
C. MacKnight, MD
From Dalhousie University (Drs. Wentzel, Rockwood, and MacKnight), Halifax, Nova Scotia; University of Western Ontario (Dr. Hachinski), London; University of Calgary (Dr. Hogan), Alberta; University of British Columbia (Dr. Feldman), Vancouver; McGill University (Drs. Wolfson and Gauthier), Montréal, Quebéc; Université Laval (Dr. Verreault), Quebéc City, Quebéc; University of Ottawa (Dr. McDowell), Ontario, Canada; and Duke University Medical Center (Dr. Østbye), Durham, NC.
V. Hachinski, MD
From Dalhousie University (Drs. Wentzel, Rockwood, and MacKnight), Halifax, Nova Scotia; University of Western Ontario (Dr. Hachinski), London; University of Calgary (Dr. Hogan), Alberta; University of British Columbia (Dr. Feldman), Vancouver; McGill University (Drs. Wolfson and Gauthier), Montréal, Quebéc; Université Laval (Dr. Verreault), Quebéc City, Quebéc; University of Ottawa (Dr. McDowell), Ontario, Canada; and Duke University Medical Center (Dr. Østbye), Durham, NC.
D. B. Hogan, MD
From Dalhousie University (Drs. Wentzel, Rockwood, and MacKnight), Halifax, Nova Scotia; University of Western Ontario (Dr. Hachinski), London; University of Calgary (Dr. Hogan), Alberta; University of British Columbia (Dr. Feldman), Vancouver; McGill University (Drs. Wolfson and Gauthier), Montréal, Quebéc; Université Laval (Dr. Verreault), Quebéc City, Quebéc; University of Ottawa (Dr. McDowell), Ontario, Canada; and Duke University Medical Center (Dr. Østbye), Durham, NC.
H. Feldman, MD
From Dalhousie University (Drs. Wentzel, Rockwood, and MacKnight), Halifax, Nova Scotia; University of Western Ontario (Dr. Hachinski), London; University of Calgary (Dr. Hogan), Alberta; University of British Columbia (Dr. Feldman), Vancouver; McGill University (Drs. Wolfson and Gauthier), Montréal, Quebéc; Université Laval (Dr. Verreault), Quebéc City, Quebéc; University of Ottawa (Dr. McDowell), Ontario, Canada; and Duke University Medical Center (Dr. Østbye), Durham, NC.
T. Østbye, PhD
From Dalhousie University (Drs. Wentzel, Rockwood, and MacKnight), Halifax, Nova Scotia; University of Western Ontario (Dr. Hachinski), London; University of Calgary (Dr. Hogan), Alberta; University of British Columbia (Dr. Feldman), Vancouver; McGill University (Drs. Wolfson and Gauthier), Montréal, Quebéc; Université Laval (Dr. Verreault), Quebéc City, Quebéc; University of Ottawa (Dr. McDowell), Ontario, Canada; and Duke University Medical Center (Dr. Østbye), Durham, NC.
C. Wolfson, MD
From Dalhousie University (Drs. Wentzel, Rockwood, and MacKnight), Halifax, Nova Scotia; University of Western Ontario (Dr. Hachinski), London; University of Calgary (Dr. Hogan), Alberta; University of British Columbia (Dr. Feldman), Vancouver; McGill University (Drs. Wolfson and Gauthier), Montréal, Quebéc; Université Laval (Dr. Verreault), Quebéc City, Quebéc; University of Ottawa (Dr. McDowell), Ontario, Canada; and Duke University Medical Center (Dr. Østbye), Durham, NC.
S. Gauthier, MD
From Dalhousie University (Drs. Wentzel, Rockwood, and MacKnight), Halifax, Nova Scotia; University of Western Ontario (Dr. Hachinski), London; University of Calgary (Dr. Hogan), Alberta; University of British Columbia (Dr. Feldman), Vancouver; McGill University (Drs. Wolfson and Gauthier), Montréal, Quebéc; Université Laval (Dr. Verreault), Quebéc City, Quebéc; University of Ottawa (Dr. McDowell), Ontario, Canada; and Duke University Medical Center (Dr. Østbye), Durham, NC.
R. Verreault, MD
From Dalhousie University (Drs. Wentzel, Rockwood, and MacKnight), Halifax, Nova Scotia; University of Western Ontario (Dr. Hachinski), London; University of Calgary (Dr. Hogan), Alberta; University of British Columbia (Dr. Feldman), Vancouver; McGill University (Drs. Wolfson and Gauthier), Montréal, Quebéc; Université Laval (Dr. Verreault), Quebéc City, Quebéc; University of Ottawa (Dr. McDowell), Ontario, Canada; and Duke University Medical Center (Dr. Østbye), Durham, NC.
I. McDowell, PhD
From Dalhousie University (Drs. Wentzel, Rockwood, and MacKnight), Halifax, Nova Scotia; University of Western Ontario (Dr. Hachinski), London; University of Calgary (Dr. Hogan), Alberta; University of British Columbia (Dr. Feldman), Vancouver; McGill University (Drs. Wolfson and Gauthier), Montréal, Quebéc; Université Laval (Dr. Verreault), Quebéc City, Quebéc; University of Ottawa (Dr. McDowell), Ontario, Canada; and Duke University Medical Center (Dr. Østbye), Durham, NC.

Notes

Address correspondence and reprint requests to Dr. Kenneth Rockwood, Division of Geriatric Medicine, Dalhousie University, QEII Health Sciences Centre, 5955 Jubilee Road, Room 1421 VMB, Halifax, Nova Scotia, Canada B3H 2E1; e-mail: [email protected]

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Fronto–Cerebellar Diaschisis and Cognitive Dysfunction after Pontine Stroke: A Case Series and Systematic Review, Biomedicines, 12, 3, (623), (2024).https://doi.org/10.3390/biomedicines12030623
    Crossref
  2. Small vessel disease burden and functional brain connectivity in mild cognitive impairment, Cerebral Circulation - Cognition and Behavior, 6, (100192), (2024).https://doi.org/10.1016/j.cccb.2023.100192
    Crossref
  3. Effects of exercise on patients with vascular cognitive impairment based on ACSM recommendations: a systematic review of randomized controlled trials, Journal of Neurology, 272, 1, (2024).https://doi.org/10.1007/s00415-024-12830-2
    Crossref
  4. Neuropsychological differential diagnosis of Alzheimer’s disease and vascular dementia: a systematic review with meta-regressions, Frontiers in Aging Neuroscience, 15, (2023).https://doi.org/10.3389/fnagi.2023.1267434
    Crossref
  5. Efficacy of acupuncture and pharmacological therapies for vascular cognitive impairment with no dementia: a network meta-analysis, Frontiers in Aging Neuroscience, 15, (2023).https://doi.org/10.3389/fnagi.2023.1181160
    Crossref
  6. Development and validation of an interpretable machine learning model—Predicting mild cognitive impairment in a high-risk stroke population, Frontiers in Aging Neuroscience, 15, (2023).https://doi.org/10.3389/fnagi.2023.1180351
    Crossref
  7. Multimodality neuroimaging in vascular mild cognitive impairment: A narrative review of current evidence, Frontiers in Aging Neuroscience, 15, (2023).https://doi.org/10.3389/fnagi.2023.1073039
    Crossref
  8. Chronic cerebral hypoperfusion: a critical feature in unravelling the etiology of vascular cognitive impairment, Acta Neuropathologica Communications, 11, 1, (2023).https://doi.org/10.1186/s40478-023-01590-1
    Crossref
  9. Altered static and dynamic functional network connectivity in post-stroke cognitive impairment, Neuroscience Letters, 799, (137097), (2023).https://doi.org/10.1016/j.neulet.2023.137097
    Crossref
  10. Trigeminal Neuralgia Is a Dementia Risk Factor: A Retrospective Cohort Study, International Journal of Environmental Research and Public Health, 19, 10, (6073), (2022).https://doi.org/10.3390/ijerph19106073
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share